Esteve Fernández1,2,3, Montse Ballbè4,5,6, Xisca Sureda7,8,9, Marcela Fu10,11,12, Esteve Saltó13,14,15, Jose M Martínez-Sánchez16,17,18. 1. Tobacco Control Unit, Cancer Prevention and Control Program, Institut Català d'Oncologia, WHO Collaborating Center for Tobacco Control, L'Hospitalet de Llobregat, Barcelona, Spain. efernandez@iconcologia.net. 2. Cancer Prevention and Control Group, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. efernandez@iconcologia.net. 3. School of Medicine, Universitat de Barcelona, Barcelona, Spain. efernandez@iconcologia.net. 4. Tobacco Control Unit, Cancer Prevention and Control Program, Institut Català d'Oncologia, WHO Collaborating Center for Tobacco Control, L'Hospitalet de Llobregat, Barcelona, Spain. mballbe@iconcologia.net. 5. Cancer Prevention and Control Group, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. mballbe@iconcologia.net. 6. Addictions Unit, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, Spain. mballbe@iconcologia.net. 7. Tobacco Control Unit, Cancer Prevention and Control Program, Institut Català d'Oncologia, WHO Collaborating Center for Tobacco Control, L'Hospitalet de Llobregat, Barcelona, Spain. xisca.sureda@gmail.com. 8. Cancer Prevention and Control Group, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. xisca.sureda@gmail.com. 9. Department of Preventive Medicine, Universidad de Alcalá, Alcalá de Henares, Spain. xisca.sureda@gmail.com. 10. Tobacco Control Unit, Cancer Prevention and Control Program, Institut Català d'Oncologia, WHO Collaborating Center for Tobacco Control, L'Hospitalet de Llobregat, Barcelona, Spain. mfu@iconcologia.net. 11. Cancer Prevention and Control Group, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. mfu@iconcologia.net. 12. School of Medicine, Universitat de Barcelona, Barcelona, Spain. mfu@iconcologia.net. 13. Cancer Prevention and Control Group, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. esteve.salto@gencat.cat. 14. School of Medicine, Universitat de Barcelona, Barcelona, Spain. esteve.salto@gencat.cat. 15. Health Plan Directorate, Ministry of Health, Generalitat de Catalunya, Spain. esteve.salto@gencat.cat. 16. Tobacco Control Unit, Cancer Prevention and Control Program, Institut Català d'Oncologia, WHO Collaborating Center for Tobacco Control, L'Hospitalet de Llobregat, Barcelona, Spain. jmmartinez@iconcologia.nets. 17. Cancer Prevention and Control Group, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. jmmartinez@iconcologia.nets. 18. Biostatistics Unit, Department of Basic Sciences, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Spain. jmmartinez@iconcologia.nets.
Abstract
OBJECTIVES: The aim of this study is to review the literature on the composition of aerosols from electronic cigarettes (e-cigarettes) originated by human vaping and to describe the emission of particulate matter ≤ 2.5 μm in diameter (PM(2.5)) from conventional and e-cigarettes at home in real-use conditions. METHODS: We conducted a systematic literature search in PubMed and Web of Science. We measured PM(2.5) in four different homes: one from a conventional cigarette smoker, one from an e-cigarette user, and two from non-smokers. RESULTS: The review identified eight previous investigations on the composition of aerosols from e-cigarettes originated by human vaping and indicated that emissions from e-cigarettes can contain potential toxic compounds such as nicotine, carbonyls, metals, and organic volatile compounds, besides particulate matter. In the observational study, the PM(2.5) median concentration was 9.88 μg/m³ in the e-cigarette user home and 9.53 and 9.36 μg/m³ in the smoke-free homes, with PM(2.5) peaks concurrent with the e-cigarette puffs. CONCLUSION: Both the literature review and the observational study indicate that e-cigarettes used under real-conditions emit toxicants, including PM(2.5). Further research is needed to characterize the chemicals emitted by different types of e-cigarettes and to assess secondhand exposure to e-cigarette aerosol using biological markers.
OBJECTIVES: The aim of this study is to review the literature on the composition of aerosols from electronic cigarettes (e-cigarettes) originated by human vaping and to describe the emission of particulate matter ≤ 2.5 μm in diameter (PM(2.5)) from conventional and e-cigarettes at home in real-use conditions. METHODS: We conducted a systematic literature search in PubMed and Web of Science. We measured PM(2.5) in four different homes: one from a conventional cigarette smoker, one from an e-cigarette user, and two from non-smokers. RESULTS: The review identified eight previous investigations on the composition of aerosols from e-cigarettes originated by human vaping and indicated that emissions from e-cigarettes can contain potential toxic compounds such as nicotine, carbonyls, metals, and organic volatile compounds, besides particulate matter. In the observational study, the PM(2.5) median concentration was 9.88 μg/m³ in the e-cigarette user home and 9.53 and 9.36 μg/m³ in the smoke-free homes, with PM(2.5) peaks concurrent with the e-cigarette puffs. CONCLUSION: Both the literature review and the observational study indicate that e-cigarettes used under real-conditions emit toxicants, including PM(2.5). Further research is needed to characterize the chemicals emitted by different types of e-cigarettes and to assess secondhand exposure to e-cigarette aerosol using biological markers.
Authors: J-F Bertholon; M H Becquemin; M Roy; F Roy; D Ledur; I Annesi Maesano; B Dautzenberg Journal: Rev Mal Respir Date: 2013-04-17 Impact factor: 0.622
Authors: Montse Ballbè; Jose M Martínez-Sánchez; Xisca Sureda; Marcela Fu; Raúl Pérez-Ortuño; José A Pascual; Esteve Saltó; Esteve Fernández Journal: Environ Res Date: 2014-09-27 Impact factor: 6.498
Authors: Arian Saffari; Nancy Daher; Ario Ruprecht; Cinzia De Marco; Paolo Pozzi; Roberto Boffi; Samera H Hamad; Martin M Shafer; James J Schauer; Dane Westerdahl; Constantinos Sioutas Journal: Environ Sci Process Impacts Date: 2014 Impact factor: 4.238
Authors: Wolfgang Schober; Katalin Szendrei; Wolfgang Matzen; Helga Osiander-Fuchs; Dieter Heitmann; Thomas Schettgen; Rudolf A Jörres; Hermann Fromme Journal: Int J Hyg Environ Health Date: 2013-12-06 Impact factor: 5.840
Authors: Christine D Czoli; Maciej L Goniewicz; Mary Palumbo; Noel Leigh; Christine M White; David Hammond Journal: Can J Public Health Date: 2019-04-25
Authors: Jay L Zweier; Mahmoud T Shalaan; Alexandre Samouilov; Ibrahim G Saleh; Mohamed A El-Mahdy Journal: Inhal Toxicol Date: 2020-11-30 Impact factor: 2.724
Authors: Kimberly G Wagoner; Micah Berman; Shyanika W Rose; Eunyoung Song; Jennifer Cornacchione Ross; Elizabeth G Klein; Dannielle E Kelley; Jessica L King; Mark Wolfson; Erin L Sutfin Journal: Tob Control Date: 2019-05-23 Impact factor: 7.552
Authors: Allison M Glasser; Lauren Collins; Jennifer L Pearson; Haneen Abudayyeh; Raymond S Niaura; David B Abrams; Andrea C Villanti Journal: Am J Prev Med Date: 2016-11-30 Impact factor: 5.043
Authors: Eric K Soule; Sarah F Maloney; Tory R Spindle; Alyssa K Rudy; Marzena M Hiler; Caroline O Cobb Journal: Tob Control Date: 2016-02-15 Impact factor: 7.552
Authors: Robert Tarran; R Graham Barr; Neal L Benowitz; Aruni Bhatnagar; Hong W Chu; Pamela Dalton; Claire M Doerschuk; M Bradley Drummond; Diane R Gold; Maciej L Goniewicz; Eric R Gross; Nadia N Hansel; Philip K Hopke; Robert A Kloner; Vladimir B Mikheev; Evan W Neczypor; Kent E Pinkerton; Lisa Postow; Irfan Rahman; Jonathan M Samet; Matthias Salathe; Catherine M Stoney; Philip S Tsao; Rachel Widome; Tian Xia; DaLiao Xiao; Loren E Wold Journal: Function (Oxf) Date: 2021-02-08